Suppr
超能文献

Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.

作者信息

Dytfeld Dominik, Matuszak Magdalena, Lewandowski Krzysztof, Komarnicki Mieczysław

出版信息

Ann Hematol. 2008 Mar;87(3):253-4. doi: 10.1007/s00277-007-0401-8. Epub 2007 Oct 23.

DOI:10.1007/s00277-007-0401-8

PMID:17955241

Abstract

摘要

相似文献

Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.

Ann Hematol. 2008 Mar;87(3):253-4. doi: 10.1007/s00277-007-0401-8. Epub 2007 Oct 23.

Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.

Hematology. 2007 Jun;12(3):235-9. doi: 10.1080/10245330701214236.

Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.

Biol Blood Marrow Transplant. 2012 Mar;18(3):486-92. doi: 10.1016/j.bbmt.2011.12.580. Epub 2011 Dec 22.

Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Blood. 2011 Nov 24;118(22):5752-8; quiz 5982. doi: 10.1182/blood-2011-05-355081. Epub 2011 Aug 17.

Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.

Leuk Lymphoma. 2005 Apr;46(4):567-9. doi: 10.1080/10428190400029700.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9.

Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.

Clin Lymphoma Myeloma. 2006 Nov;7(3):210-6. doi: 10.3816/CLM.2006.n.061.

Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.

Haematologica. 2014 Mar;99(3):e33-4. doi: 10.3324/haematol.2013.100396. Epub 2014 Feb 14.

A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6313-22. eCollection 2014.

Successful treatment of lymph node extramedullary plasmacytoma with bortezomib.

Ann Hematol. 2006 Mar;85(3):188-90. doi: 10.1007/s00277-005-0052-6. Epub 2006 Jan 6.

引用本文的文献

Autophagy in Hematological Malignancies.

Cancers (Basel). 2022 Oct 17;14(20):5072. doi: 10.3390/cancers14205072.

Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report.

J Med Case Rep. 2014 Sep 8;8:299. doi: 10.1186/1752-1947-8-299.

A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment.

Case Rep Oncol. 2011 Feb 25;4(1):101-5. doi: 10.1159/000324920.

Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report.

Cases J. 2009 Sep 14;2:7456. doi: 10.4076/1757-1626-2-7456.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译